Esperion Therapeutics (ESPR) EPS (Basic) (2012 - 2026)
Esperion Therapeutics (ESPR) posted EPS (Basic) of -$0.1 for Q1 2026, down 134.85% on a QoQ basis from $0.3 in Q4 2025, and up 50.43% year-over-year from -$0.07 in Q1 2025.
Esperion Therapeutics (ESPR) EPS (Basic) (2012 - 2026) Analysis & Trends
Esperion Therapeutics' EPS (Basic) history runs 15 years deep, the most recent figure standing at -$0.1 for Q1 2026.
- Quarterly EPS (Basic) rose 50.43% year-over-year to -$0.1 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$0.04 (up 93.65% YoY) and the FY2025 annual result came in at -$0.11, up 60.53% from the prior year.
- EPS (Basic) was -$0.1 for Q1 2026 at Esperion Therapeutics, down from $0.3 in the prior quarter.
- Across five years, EPS (Basic) topped out at $0.34 in Q1 2024 and bottomed at -$1.05 in Q2 2022.
- A 5-year average of -$0.36 and a median of -$0.21 in 2025 frame the typical range for EPS (Basic).
- Peak annual rise in EPS (Basic) reached 293.86% in 2025, while the deepest fall reached 161.53% in 2025.
- Esperion Therapeutics' EPS (Basic) stood at -$0.86 in 2022, then soared by 34.93% to -$0.56 in 2023, then soared by 72.11% to -$0.16 in 2024, then surged by 293.86% to $0.3 in 2025, then plunged by 134.85% to -$0.1 in 2026.
- Business Quant data shows ESPR's EPS (Basic) at -$0.1 in Q1 2026, $0.3 in Q4 2025, and -$0.16 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 0.32 |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 1.42 |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | -1.49 |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 6.32 |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | 0.15 |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 1.97 |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 0.11 |
| 10 | Esperion Therapeutics | 799.30 Mn | 643.14 Mn | 45.53 Mn | -0.10 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.10 |
| Dec 31, 2025 | 0.30 |
| Sep 30, 2025 | -0.16 |
| Jun 30, 2025 | -0.07 |
| Mar 31, 2025 | -0.21 |
| Dec 31, 2024 | -0.16 |
| Sep 30, 2024 | -0.16 |
| Jun 30, 2024 | -0.06 |
| Mar 31, 2024 | 0.34 |
| Dec 31, 2023 | -0.56 |
| Sep 30, 2023 | -0.38 |
| Jun 30, 2023 | -0.47 |
| Mar 31, 2023 | -0.80 |
| Dec 31, 2022 | -0.86 |
| Sep 30, 2022 | -0.82 |
| Jun 30, 2022 | -1.05 |
| Mar 31, 2022 | -0.94 |
| Dec 31, 2021 | -2.39 |
| Sep 30, 2021 | -2.62 |
| Jun 30, 2021 | -1.67 |